Skip to main content
Tech.euFundingExplorerBeta

Jens von Bahr

Investor profile

Jens von Bahr has backed 3 European tech companies across 3 funding rounds between 2017 and 2024, joining rounds totalling €19M. Most active in E-commerce and Consumer. Data as of Nov 2026.

Deals
3
distinct rounds
Companies
3
backed
Active span
2017–2024
8 yrs
Total round €
€19M
sum of rounds joined

Deals by year

distinct rounds / year
Jens von Bahr — deals by year — interactive chart.
Data table
Jens von Bahr — deals by year
20171
20211
20241

Top sectors

by deals
Jens von Bahr — top sectors — interactive chart.
Data table
Jens von Bahr — top sectors
E-commerce1
Consumer1
Fintech1
Healthtech1

Stages

by deals
Jens von Bahr — stages — interactive chart.
Data table
Jens von Bahr — stages
Other3

Countries

by deals
Jens von Bahr — countries — interactive chart.
Data table
Jens von Bahr — countries
Sweden3

Co-investment network

shared rounds
Co-investment network — interactive chart.
Jens von Bahr — 3 dealsJens von BahrFredrik Österberg — 2 shared deals · click to openFredrik ÖsterbergBo Mattsson — 1 shared deals · click to openBo MattssonErnström & Co — 1 shared deals · click to openErnström & CoFilip Engelbert — 1 shared deals · click to openFilip EngelbertInbox Capital — 1 shared deals · click to openInbox CapitalJ12 Ventures — 1 shared deals · click to openJ12 VenturesJoen Bonnier — 1 shared deals · click to openJoen BonnierJonas Engwall — 1 shared deals · click to openJonas EngwallJonas Nordlander — 1 shared deals · click to openJonas NordlanderMagnus Rausing — 1 shared deals · click to openMagnus RausingNorrsken Launcher — 1 shared deals · click to openNorrsken LauncherTom Dinkelspiel — 1 shared deals · click to openTom Dinkelspiel

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
ZaverSweden1€11M
CellcolabsSweden1€8.0M
BarnebysSweden1€0

Biggest deals

top 10 by amount
CompanyStageAmountDate
ZaverOther€11M2021-10
CellcolabsOther€8.0M2024-03
BarnebysOther—2017-04
← Back to investors